Health economic evaluation of vaccination strategies for the prevention of herpes zoster and postherpetic neuralgia in Germany
Conclusions:
According to our evaluation, HZ-vaccination is expected to avoid HZ/PHN-cases and gain QALYs to higher costs. However, the vaccine price had the highest impact on the ICERs. Among different scenarios, targeting individuals aged 60 years seems to represent the most cost-effective vaccination-strategy.
Source: BMC Health Services Research - Category: Journals (General) Authors: Bernhard UltschFelix WeidemannThomas ReinholdAnette SiedlerGérard KrauseOle Wichmann Source Type: research
More News: Clinical Trials | Epidemiology | General Medicine | Herpes | Pain | Shingles (Herpes Zoster) Vaccine | Skin | Vaccines | Varicella-Zoster Virus Vaccine